Elevation Wealth Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165 | Hold |
3
| – | – | ﹤0.01% | 460 |
|
|
2025
Q1 | $213 | Hold |
3
| – | – | ﹤0.01% | 462 |
|
|
2024
Q4 | $198 | Hold |
3
| – | – | ﹤0.01% | 467 |
|
|
2024
Q3 | $211 | Hold |
3
| – | – | ﹤0.01% | 450 |
|
|
2024
Q2 | $247 | Hold |
3
| – | – | ﹤0.01% | 477 |
|
|
2024
Q1 | $263 | Hold |
3
| – | – | ﹤0.01% | 444 |
|
|
2023
Q4 | $266 | Hold |
3
| – | – | ﹤0.01% | 416 |
|
|
2023
Q3 | $266 | Hold |
3
| – | – | ﹤0.01% | 315 |
|
|
2023
Q2 | $261 | Hold |
3
| – | – | ﹤0.01% | 327 |
|
|
2023
Q1 | $292 | Buy |
+3
| New | +$292 | ﹤0.01% | 327 |
|